Human Sex Matters: Y-Linked Lysine Demethylase 5D Drives Accelerated Male Craniofacial Osteogenic Differentiation.
Madlen MertenJohannes Friedrich Wilhelm GreinerTarek NiemannMeike Grosse VenhausDaniel KronenbergRichard StangeDirk WähnertChristian KaltschmidtThomas VordemvenneBarbara KaltschmidtPublished in: Cells (2022)
Female sex is increasingly associated with a loss of bone mass during aging and an increased risk of developing nonunion fractures. Hormonal factors and cell-intrinsic mechanisms are suggested to drive these sexual dimorphisms, although underlying molecular mechanisms are still a matter of debate. Here, we observed a decreased capacity of calvarial bone recovery in female rats and a profound sexually dimorphic osteogenic differentiation in human adult neural crest-derived stem cells (NCSCs). Next to an elevated expression of pro-osteogenic regulators, global transcriptomics revealed Lysine Demethylase 5D (KDM5D) to be highly upregulated in differentiating male NCSCs. Loss of function by siRNA or pharmacological inhibition of KDM5D significantly reduced the osteogenic differentiation capacity of male NCSCs. In summary, we demonstrated craniofacial osteogenic differentiation to be sexually dimorphic with the expression of KDM5D as a prerequisite for accelerated male osteogenic differentiation, emphasizing the analysis of sex-specific differences as a crucial parameter for treating bone defects.
Keyphrases
- cell therapy
- mesenchymal stem cells
- stem cells
- bone marrow
- endothelial cells
- bone mineral density
- bone regeneration
- single cell
- transcription factor
- mental health
- induced pluripotent stem cells
- bone loss
- drug delivery
- computed tomography
- pluripotent stem cells
- autism spectrum disorder
- contrast enhanced
- amino acid
- insulin resistance